46 studies found for:    Open Studies | "Myositis"
Show Display Options
Rank Status Study
21 Recruiting Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
Condition: Sarcopenia
Intervention:
22 Recruiting Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
Condition: Glycogen Storage Disease Type III
Interventions: Dietary Supplement: FAXE Kondi;   Dietary Supplement: Faxe Kondi Free
23 Recruiting Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
Condition: MYOPATHY
Intervention: Biological: hematopoietic stem cell transplantation
24 Not yet recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
25 Recruiting Pregnancy and Medically Assisted Conception in Rare Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Systemic Lupus Erythematosus;   Antiphospholipid Syndrome;   Sjogren Syndrome;   Scleroderma;   Myositis;   Vasculitis;   Mastocytosis;   Various Autoimmune and/or Systemic and/or Rare Diseases
Intervention:
26 Recruiting An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Intervention: Drug: Palovarotene
27 Recruiting An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene;   Drug: Placebo
28 Recruiting A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva
Intervention:
29 Recruiting Dermatomyositis and Polymyositis Registry
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Acthar
30 Recruiting Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Condition: Polymyositis
Interventions: Drug: Placebo;   Drug: BAF312
31 Recruiting Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Condition: Dermatomyositis
Interventions: Drug: JBT-101;   Drug: Placebo
32 Not yet recruiting Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Conditions: Osteoporosis;   Juvenile Rheumatoid Arthritis;   Dermatomyositis;   Polyarthritis;   Systemic Lupus Erythematosis;   Vasculitis;   Glucocorticoid-induced Osteoporosis
Intervention: Drug: denosumab
33 Recruiting Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
Condition: Dermatomyositis
Intervention: Drug: Immunoglobulin (Hizentra)
34 Recruiting Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Conditions: Dermatomyositis;   Juvenile Dermatomyositis
Intervention: Drug: H.P. Acthar Gel
35 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
36 Recruiting Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Conditions: Dermatomyositis;   Polymyositis
Interventions: Drug: tocilizumab;   Drug: placebo
37 Recruiting Safety and Efficacy of BAF312 in Dermatomyositis
Condition: Active Dermatomyositis
Interventions: Drug: BAF312 0.5 mg;   Drug: BAF312 2 mg;   Drug: BAF312 10 mg;   Drug: Placebo to BAF312
38 Recruiting Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Conditions: Dermatomyositis;   Polymyositis
Intervention: Drug: Adrenocorticotropic Hormone Gel
39 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)
Intervention: Drug: Baricitinib
40 Recruiting Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis
Condition: Dermatomyositis Associated Superficial Calcinosis
Interventions: Device: Fractional Carbon Dioxide (FCO2) Laser (Candela QuadraLase (TM));   Drug: Sodium thiosulfate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Indicates status has not been verified in more than two years